PatientsVille.com Logo

PatientsVille

Dekristol Side Effects

Common Dekristol Side Effects


The most commonly reported Dekristol side effects (click to view or check a box to report):

Bone Pain (5)
Fall (3)
Gait Disturbance (3)
Joint Arthroplasty (2)
Pain (2)
Joint Injury (2)
Dyspnoea (2)
Hospitalisation (2)
Coccydynia (2)
Pelvic Fracture (2)
Peripheral Arterial Occlusive Disease (2)
Surgery (2)
Lumbar Spinal Stenosis (2)
Sensation Of Heaviness (2)
Sciatica (2)
Postoperative Wound Infection (2)
Bacterial Infection (1)
Abdominal Distension (1)
Hypotension (1)
Blood Pressure Increased (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Dekristol Side Effects Reported to FDA

The following Dekristol reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Dekristol on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Breast Cancer
This is a report of a 67-year-old female patient (weight: NA) from GERMANY, suffering from the following symptoms/conditions: NA, who was treated with Dekristol (dosage: NA, start time: May 01, 1997), combined with:
  • Mabthera (4000 Mg)
  • Methotrexate
  • Atacand
and developed a serious reaction and side effect(s). The consumer presented with:
  • Breast Cancer
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dekristol treatment in female patients, resulting in breast cancer side effect. The patient was hospitalized.

Pelvic Fracture, Joint Arthroplasty, Postoperative Wound Infection
This report suggests a potential Dekristol Pelvic Fracture, Joint Arthroplasty, Postoperative Wound Infection side effect(s) that can have serious consequences. A female patient (weight: NA) from GERMANY was diagnosed with the following symptoms/conditions: osteoporosis,rheumatoid arthritis and used Dekristol (dosage: Qs) starting Feb 01, 2011. Soon after starting Dekristol the patient began experiencing various side effects, including:
  • Pelvic Fracture
  • Joint Arthroplasty
  • Postoperative Wound Infection
Drugs used concurrently:
  • Arcoxia
  • Pantoprazole (40 1x1)
  • Tebesium
  • Cimzia (Number Of Doses Received: 22)
  • Methotrexate Sodium (Qs)
  • Enoxaparin Sodium
  • Prednisolone
  • Methotrexate Sodium (20 Mg/w)
The patient was hospitalized. Although Dekristol demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as pelvic fracture, may still occur.

Rheumatoid Arthritis
This Rheumatoid Arthritis problem was reported by a physician from GERMANY. A 61-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: vitamin d deficiency,rheumatoid arthritis. On Nov 24, 2011 this consumer started treatment with Dekristol (dosage: 20.000 Ie Weekly). The following drugs were being taken at the same time:
  • Diclofenac
  • Pantoprazole
  • Folsan (5mg Weekly)
  • Folic Acid (5mg Weekly)
  • Pantoprazole
  • Methotrexate
  • Diclofenac
  • Pantoprazole
When commencing Dekristol, the patient experienced the following unwanted symptoms/side effects:
  • Rheumatoid Arthritis
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as rheumatoid arthritis, may become evident only after a product is in use by the general population.

Pulmonary Function Test Decreased, Heart Valve Calcification, Dyspnoea
This is a report of a 82-year-old female patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: NA and was treated with Dekristol (dosage: 3 Df, Weekly (1/w)) starting Jan 14, 2011. Concurrently used drugs:
  • Antihypertensives
  • Forteo (Unk, Qd)
Soon after that, the consumer experienced the following side effects:
  • Pulmonary Function Test Decreased
  • Heart Valve Calcification
  • Dyspnoea
This opens a possibility that Dekristol treatment could cause the above reactions, including pulmonary function test decreased, and some female subjects may be more susceptible.


Joint Arthroplasty, Pelvic Fracture, Postoperative Wound Infection
A female patient (weight: NA) from GERMANY with the following symptoms/conditions: osteoporosis,rheumatoid arthritis,antibiotic prophylaxis,thrombosis prophylaxis started Dekristol treatment (dosage: Qs) on May 15, 2006. Soon after starting Dekristol treatment, the subject experienced various side effects, including:
  • Joint Arthroplasty
  • Pelvic Fracture
  • Postoperative Wound Infection
Concurrently used drugs:
  • Arcoxia
  • Tebesium
  • Enoxaparin Sodium
  • Methotrexate Sodium (Qs)
  • Certolizumab Pegol (Number Of Doses Received: 22)
  • Prednisolone
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Dekristol.

Parathyroidectomy
A male patient from GERMANY (weight: NA) experienced symptoms, such as: NA and was treated with Dekristol(dosage: NA). The treatment was initiated on Oct 27, 2010. After that a consumer reported the following side effect(s):
  • Parathyroidectomy
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Dekristol efficacy:
  • Renvela
  • Omeprazole
  • Bisoprolol Fumarate
  • Zemplar
  • Retacrit
  • Simva Basic
  • Fosrenol
  • Ferrelecit
The patient was hospitalized.

Maternal Exposure During Pregnancy, Ovarian Cyst
In this report, Dekristol was administered for the following condition: NA.A 0-year-old female consumer from GERMANY (weight: NA) started Dekristol treatment (dosage: Once Every 14 Days.) on Aug 03, 2010.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Maternal Exposure During Pregnancy
  • Ovarian Cyst
A possible interaction with other drugs could have contributed to this reaction:
  • Levothyroxine Sodium (100 [ug/d ]/ 50ug/d Until March 2011, From March 2011 100ug/d)
  • Metformin Hcl (2000 [mg/d (2x1000) ])
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Dekristol treatment could be related to the listed above side effect(s).

Fall, Knee Arthroplasty, Vascular Graft, Balance Disorder, Hospitalisation, Asthenia, Blood Pressure Increased
This is a report of the following Dekristol side effect(s):
  • Fall
  • Knee Arthroplasty
  • Vascular Graft
  • Balance Disorder
  • Hospitalisation
  • Asthenia
  • Blood Pressure Increased
A 74-year-old female patient from GERMANY (weight: NA) presented with the following condition: NA and received a treatment with Dekristol (dosage: NA) starting: May 21, 2010.The following concurrently used drugs could have generated interactions:
  • Humira
  • Ibuprofen Tablets
  • Prednisolone (Unk)
  • Calcium
  • Forteo (Unk, Qd)
The patient was hospitalized.This report suggests that a Dekristol treatment could be associated with the listed above side effect(s).

Choking Sensation, Chest Discomfort, Cardiovascular Disorder, Tachycardia, Hypotension, Hypertensive Crisis, Dyspnoea, Hyperhidrosis
This Dekristol report was submitted by a male consumer from GERMANY (weight: NA). The patient was diagnosed with: NA and Dekristol was administered (dosage: 20000iu Weekly) starting: Oct 23, 2011. The consumer developed a set of symptoms:
  • Choking Sensation
  • Chest Discomfort
  • Cardiovascular Disorder
  • Tachycardia
  • Hypotension
  • Hypertensive Crisis
  • Dyspnoea
  • Hyperhidrosis
Other drugs used simultaneously:
  • Votrient (400mg Per Day)
  • Aspirin (100mg Per Day)
  • Amlodipine (5mg Per Day)
  • Diovan (160mg Twice Per Day)
  • Bisoprolol Fumarate (2.5mg Per Day)
  • Simvastatin (20mg Per Day)
The patient was hospitalized.Those unexpected symptoms could be linked to a Dekristol treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Sudden Hearing Loss
This is a report of a possible correlation between Dekristol use and the following symptoms/side effect(s):
  • Sudden Hearing Loss
which could contribute to an assessment of Dekristol risk profile.A 84-year-old female consumer from GERMANY (weight: NA) was suffering from NA and was treated with Dekristol (dosage: NA) starting Aug 18, 2010.Other concurrent medications:
  • Calcium
  • Forteo (Unk, Qd)
The patient was hospitalized.

Hyperkalaemia, Renal Failure Acute, Acidosis
A 69-year-old female patient from GERMANY (weight: NA) presented with the following symptoms: NA and after a treatment with Dekristol (colecalciferol) (dosage: NA) experienced the following side effect(s):
  • Hyperkalaemia
  • Renal Failure Acute
  • Acidosis
The treatment was started on Aug 01, 2011. Dekristol (colecalciferol) was used in combination with the following drugs:
  • Prednisone Tab
  • Adenuric (febuxostat) (120 Milligrams (daily) Oral)
  • Oxycodone Hcl
  • Bondiol (alfacalcidol)
The patient was hospitalized.This report could alert potential Dekristol (colecalciferol) consumers.

Spinal Compression Fracture, Bone Pain
In this report, a female patient from GERMANY (weight: NA) was affected by a possible Dekristol side effect.The patient was diagnosed with osteoporosis. After a treatment with Dekristol (dosage: 2000 Iu/week, start date: Feb 07, 2011), the patient experienced the following side effect(s):
  • Spinal Compression Fracture
  • Bone Pain
The following simultaneously used drugs could have led to this reaction:
  • Zoledronoc Acid (5 Mg Once Yearly)
  • Zoledronoc Acid (5 Mg, Unk)
The findings here stress that side effects should be taken into consideration when evaluating a Dekristol treatment.

Transplant Rejection
This is a report of a male patient from GERMANY (weight: NA), who used Dekristol (dosage: 1 Dose Form /month) for a treatment of NA. After starting a treatment on Dec 10, 2011, the patient experienced the following side effect(s):
  • Transplant Rejection
The following drugs could possibly have interacted with the Dekristol treatment
  • Basiliximab (Last Dose Prior To Sae 17/apr/2011)
  • Metformin Hcl
  • Prednisolone
  • Pantoprazole
  • Bicanorm
  • Tacrolimus (Last Dose Prior To Sae 10/dec/2011)
  • Fluvastatin
  • Repaglinid
The patient was hospitalized.Taken together, these observations suggest that a Dekristol treatment could be related to side effect(s), such as Transplant Rejection.

Abdominal Discomfort, Diarrhoea, Syncope, Vasculitis Cerebral, Cerebral Disorder, Abdominal Distension, Regurgitation
This abdominal discomfort side effect was reported by a consumer or non-health professional from GERMANY. A male patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Dekristol (dosage: Unk Ukn, Unk), which was started on Apr 01, 2011. Concurrently used drugs:
  • Steroids (Unk Ukn, Unk)
  • Myfortic (360 Mg Twice Daily)
  • Angiotensin Ii Antagonists (Unk Ukn, Unk)
When starting to take Dekristol the consumer reported the following symptoms:
  • Abdominal Discomfort
  • Diarrhoea
  • Syncope
  • Vasculitis Cerebral
  • Cerebral Disorder
  • Abdominal Distension
  • Regurgitation
The patient was hospitalized. These side effects may potentially be related to Dekristol.

Wrist Fracture, Osteoporotic Fracture, Fall
This is a Dekristol side effect report of a 85-year-old female patient (weight:NA) from GERMANY, suffering from the following symptoms/conditions: NA, who was treated with Dekristol (dosage:Unk Unk, Qwk, start time: Feb 15, 2011), combined with:
  • Prolia (Unk)
, and developed a serious reaction and a wrist fracture side effect. The patient presented with:
  • Wrist Fracture
  • Osteoporotic Fracture
  • Fall
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Dekristol treatment in female patients suffering from NA, resulting in wrist fracture.

Surgery, Knee Operation, Hospitalisation, Bacterial Infection, Haematoma
This report suggests a potential Dekristol surgery side effect(s) that can have serious consequences. A 60-year-old female patient from GERMANY (weight:NA) was diagnosed with the following health condition(s): NA and used Dekristol (dosage: Unk, Weekly (1/w)) starting Jan 24, 2011. Soon after starting Dekristol the patient began experiencing various side effects, including:
  • Surgery
  • Knee Operation
  • Hospitalisation
  • Bacterial Infection
  • Haematoma
Drugs used concurrently:
  • Forteo (Unk, Qd)
  • Enbrel
  • Cortisone Acetate (Unk, Prn)
The patient was hospitalized. Although Dekristol demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as surgery, may still occur.

C-reactive Protein Increased, Neuroleptic Malignant Syndrome, Blood Creatine Phosphokinase Increased, Pyrexia, Neutropenia, Sepsis, Fall, Gait Disturbance
This c-reactive protein increased problem was reported by a health professional from UNITED KINGDOM. A male patient (weight: NA) was diagnosed with the following medical condition(s): vitamin d decreased,schizophrenia, paranoid type,blood cholesterol increased,iron deficiency anaemia,urinary tract disorder,gastrooesophageal reflux disease,salivary hypersecretion,depression.On Feb 28, 2011 a consumer started treatment with Dekristol (dosage: 2 Df, Every 4/52). The following drugs/medications were being taken at the same time:
  • Clozaril (325 Mg/ Day)
  • Simvastatin (40 Mg/day)
  • Ferrous Sulfate Tab (200 Mg, Tid)
  • Tamsulosin Hydrochloride (400 Ug/ Day)
  • Omeprazole (10 Mg, Bid)
  • Hyoscine Hydrobromide (300 Ug, Tid)
  • Escitalopram (10 Mg/ Day)
When commencing Dekristol, the patient experienced the following unwanted symptoms /side effects:
  • C-reactive Protein Increased
  • Neuroleptic Malignant Syndrome
  • Blood Creatine Phosphokinase Increased
  • Pyrexia
  • Neutropenia
  • Sepsis
  • Fall
  • Gait Disturbance
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as c-reactive protein increased, may become evident only after a product is in use by the general population.

Neoplasm Malignant, Neoplasm Progression, Lymphoedema, Lymphangiosis Carcinomatosa, Pain, Renal Failure
This is a Dekristol side effect report of a male patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: NA and was treated with Dekristol (dosage: NA) starting Dec 13, 2010. Concurrently used drugs:
  • Thyronajod
  • Samarium (2.5 Gbq, Unk)
  • Vinflunine (458 Mg, Unk)
  • Zometa (4 Mg, Every 4 Weeks)
  • Bisoprolol
  • Palladone
  • Gemcitabine Hydrochloride (1830 Mg, Unk)
  • Torsemide (Unk)
Soon after that, the consumer experienced the following of symptoms:
  • Neoplasm Malignant
  • Neoplasm Progression
  • Lymphoedema
  • Lymphangiosis Carcinomatosa
  • Pain
  • Renal Failure
This opens a possibility that Dekristol could cause neoplasm malignant and that some male patients may be more susceptible.

Sciatica, Bone Pain, Joint Injury, Lumbar Spinal Stenosis, Peripheral Arterial Occlusive Disease, Coccydynia, Gait Disturbance, Sensation Of Heaviness
A 83-year-old female patient (weight: NA) from GERMANY with the following symptoms: NA started Dekristol 20000 treatment (dosage: 1 Unk, Unk) on May 12, 2011. Soon after starting Dekristol 20000 treatment, the consumer experienced several side effects, including:
  • Sciatica
  • Bone Pain
  • Joint Injury
  • Lumbar Spinal Stenosis
  • Peripheral Arterial Occlusive Disease
  • Coccydynia
  • Gait Disturbance
  • Sensation Of Heaviness
. Concurrently used drugs:
  • Prolia (60 Mg, Unk)
This finding indicates that some patients can be more vulnerable to developing Dekristol 20000 side effects, such as sciatica.

Bone Pain, Lumbar Spinal Stenosis, Peripheral Arterial Occlusive Disease, Gait Disturbance, Sciatica, Joint Injury, Coccydynia, Sensation Of Heaviness
This bone pain side effect was reported by a consumer or non-health professional from GERMANY. A 83-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Dekristol 20000 (dosage: 1 Unk, Unk), which was started on May 12, 2011. Concurrently used drugs:
  • Prolia (60 Mg, Unk)
.When starting to take Dekristol 20000 the consumer reported symptoms, such as:
  • Bone Pain
  • Lumbar Spinal Stenosis
  • Peripheral Arterial Occlusive Disease
  • Gait Disturbance
  • Sciatica
  • Joint Injury
  • Coccydynia
  • Sensation Of Heaviness
These side effects may potentially be related to Dekristol 20000.

Vertebral Wedging, Bone Pain, Thoracic Vertebral Fracture
This is a report of a female patient (weight: NA) from GERMANY, suffering from the following symptoms/conditions: osteoporosis, who was treated with Dekristol (dosage: Unk Ukn, Unk, start time: Dec 15, 2009), combined with:
  • Asthma-spray
  • Zoledronoc Acid (5 Mg, Unk)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Vertebral Wedging
  • Bone Pain
  • Thoracic Vertebral Fracture
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dekristol treatment in female patients, resulting in vertebral wedging side effect.

Atrial Fibrillation
This report suggests a potential Dekristol Atrial Fibrillation side effect(s) that can have serious consequences. A 64-year-old female patient (weight: NA) from GERMANY was diagnosed with the following symptoms/conditions: NA and used Dekristol (dosage: 20000 Iu, Weekly) starting Apr 12, 2010. Soon after starting Dekristol the patient began experiencing various side effects, including:
  • Atrial Fibrillation
Drugs used concurrently:
  • Prednisolone (7.5 Mg, 1x/day)
  • Methotrexate Sodium (25 Mg, Weekly)
  • Etanercept (50 Mg, Qwk)
The patient was hospitalized. Although Dekristol demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as atrial fibrillation, may still occur.

Ureteral Catheterisation, Renal Transplant, Surgery
This Ureteral Catheterisation, Renal Transplant, Surgery problem was reported by a physician from GERMANY. A 67-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Mar 17, 2004 this consumer started treatment with Dekristol (dosage: NA). The following drugs were being taken at the same time:
  • Vitamin B6
  • Venofer
  • Simvastatin
When commencing Dekristol, the patient experienced the following unwanted symptoms/side effects:
  • Ureteral Catheterisation
  • Renal Transplant
  • Surgery
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as ureteral catheterisation, may become evident only after a product is in use by the general population.

Bone Infarction
This is a report of a 47-year-old male patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: osteoporosis and was treated with Dekristol (dosage: Dose 20000 Ie Freq: Qa) starting Mar 01, 2010. Concurrently used drugs:
  • Folic Acid (Route : 144)
  • Alendronic Acid
  • Hydrochlorothiazide-beta
  • Prednisolone
  • Amlodipine
  • Omeprazole (Route 144)
  • Cimzia (No Of Doses Received :21)
  • Methotrexate (Qs)
Soon after that, the consumer experienced the following side effects:
  • Bone Infarction
This opens a possibility that Dekristol treatment could cause the above reactions, including bone infarction, and some male subjects may be more susceptible.

Systemic Lupus Erythematosus
A female patient (weight: NA) from GERMANY with the following symptoms/conditions: osteoporosis started Dekristol treatment (dosage: NA) on Aug 13, 2009. Soon after starting Dekristol treatment, the subject experienced various side effects, including:
  • Systemic Lupus Erythematosus
Concurrently used drugs:
  • Boniva
  • Digitoxin Tab (Frequency 1-0-0)
  • Ramipril (Frequency 1-0-0)
  • Marcumar (According To Inr)
This finding indicates that some female patients could be more vulnerable to Dekristol.

1 of 2 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Dekristol Side Effects

    Did You Have a Dekristol Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Dekristol for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Dekristol Safety Alerts, Active Ingredients, Usage Information

    More About Dekristol

    Side Effects reported to FDA: 29

    Dekristol safety alerts: No

    Reported hospitalizations: 18

    Latest Dekristol clinical trials

    Dekristol Reviews

    No reviews, be a first to report a side effect via side effect reporting form